Add to ORKGContinuous glucose monitor devices, such as the Dexcom, plays a huge role in lowering A1C, advancing individual diabetic management, and preventing diabetic complications. Through the following research, connections have been made between the goal of continuous glucose monitoring devices being more convenient for patients and the positive impact towards managing glucose trends and hemoglobin A1C levels
Introduction: Normoglycaemia in people with diabetes results in improved outcome. Continuous glucose...
The purpose of this study is to investigate the economic and clinical costs and benefits of continuo...
The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many t...
Home glucose monitoring was revolutionized in 1999 when the U.S. Food and Drug Administration (FDA) ...
ABSTRACT Introduction: Blood glucose monitoring has evolved over the 20th century into a vital compo...
Type-1 diabetes is a disease of subtle complexities. Patients struggle to understand glucose pattern...
Objective/Methods: Barriers to continuous glucose monitoring (CGM) use continue to hamper adoption o...
Continuous glucose monitors (CGMs) are used to measure a patient’s glucose levels every few minutes ...
In our study we retrospectively looked at patients in which as a standard of care Continuous Glucose...
Glycated hemoglobin A1c (HbA1c) is routinely used as a marker of average glycemic control, but it fa...
Numerous randomized controlled trials (RCTs) have demonstrated the glycemic benefits of continuous g...
This article details perspectives from two individuals with type 1 diabetes (T1DM) who use continuou...
Controlling glycemia in diabetes remains key to prevent complications in this condition. However, gl...
With the emphasis on intensive management of type 1 diabetes, data from studies support frequent mon...
In type 1 diabetes (T1D) the individual's immune system attacks the insulin producing beta cells of ...
Introduction: Normoglycaemia in people with diabetes results in improved outcome. Continuous glucose...
The purpose of this study is to investigate the economic and clinical costs and benefits of continuo...
The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many t...
Home glucose monitoring was revolutionized in 1999 when the U.S. Food and Drug Administration (FDA) ...
ABSTRACT Introduction: Blood glucose monitoring has evolved over the 20th century into a vital compo...
Type-1 diabetes is a disease of subtle complexities. Patients struggle to understand glucose pattern...
Objective/Methods: Barriers to continuous glucose monitoring (CGM) use continue to hamper adoption o...
Continuous glucose monitors (CGMs) are used to measure a patient’s glucose levels every few minutes ...
In our study we retrospectively looked at patients in which as a standard of care Continuous Glucose...
Glycated hemoglobin A1c (HbA1c) is routinely used as a marker of average glycemic control, but it fa...
Numerous randomized controlled trials (RCTs) have demonstrated the glycemic benefits of continuous g...
This article details perspectives from two individuals with type 1 diabetes (T1DM) who use continuou...
Controlling glycemia in diabetes remains key to prevent complications in this condition. However, gl...
With the emphasis on intensive management of type 1 diabetes, data from studies support frequent mon...
In type 1 diabetes (T1D) the individual's immune system attacks the insulin producing beta cells of ...
Introduction: Normoglycaemia in people with diabetes results in improved outcome. Continuous glucose...
The purpose of this study is to investigate the economic and clinical costs and benefits of continuo...
The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many t...